64 results
8-K
EX-10.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
, licensee, supplier, or other business relation of the Company Group, or any such relation that was a client, customer, licensee, supplier, or other business
SC TO-T
EX-99
LJPC
La Jolla Pharmaceutical Co.
25 Jul 22
Third party tender offer statement
8:34am
, business methods, product plans, standard operating procedures, budgets, forecasts, customer lists, supplier information, information discovered
8-K
EX-10.1
INVA
Innoviva Inc
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm
development methodologies, algorithms, technical information, proprietary business information, customer and supplier lists, customer and supplier records
SC TO-C
EX-2.1
INVA
Innoviva Inc
11 Jul 22
Information about tender offer
3:46pm
Companies during such period.
(d) As of the date of this Agreement, the Company has not received any written notice indicating that any supplier
8-K
EX-2.1
k3659mh1vqlx7lec
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
jivspr
11 Jul 22
Business combination disclosure
7:38am
8-K
EX-10.1
2567n jetf7ph
12 Jun 20
Departure of Directors or Certain Officers
4:42pm
8-K
EX-10.3
lbm l88kgir
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.8
62vpmr4vxgzb8eplow3
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
424B5
4fl3omn34h
18 Jan 13
Prospectus supplement for primary offering
12:00am